Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's LG Life Sciences Teams with Macrogen to Pool Genetics Databases for Personalized Medicines and Theranostics

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's LG Life Sciences hopes to bring new life to its stalled oncology program by inking a memorandum of understanding with genomic services provider Macrogen to work together for the development and commercialization of personalized medicine using patients' genetic information
Advertisement

Related Content

LG Life Sciences' 2nd Quarter Sales Dampened By Strong Won, Tightened Regulatory Watch On Pharma
LG Life Sciences-Green Cross Tie-up Might Not Trigger Matching Alliances By Other Korean Drug Makers
LG Life Sciences-Green Cross Tie-up Might Not Trigger Matching Alliances By Other Korean Drug Makers
Advertisement
UsernamePublicRestriction

Register

SC075631

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel